C-RAD reports Q3 financial results with declining orders
Revenue fell 24% to MSEK 85 while order intake dropped 29%. A US customer cancellation reduced the backlog by 13%, though gross margin improved to 76% driven by service revenue growth.
See the latest news and media coverage for C-RAD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiation oncology technology company
c-rad.comLast updated
In short: C-RAD's Q3 2026 revenue fell 24% as orders dropped and a US cancellation cut backlog
Revenue fell 24% to MSEK 85 while order intake dropped 29%. A US customer cancellation reduced the backlog by 13%, though gross margin improved to 76% driven by service revenue growth.
Revenue grew 1% to MSEK 226. Restructuring completed, shifting focus to acceleration and software partnerships.
CEO Tomas Blomquist states it marks an important phase with increased pace and prioritization on value drivers.
Order intake rose 19% to MSEK 115 while revenue fell 12%. CEO Tomas Blomquist launched an integrated growth strategy.
Medtech company C-Red reports a post-tax result of SEK 10 million for the third quarter of 2026 (13).
Earnings call C-RAD delivered strong Q3 results with 16% revenue growth and an 11% rise in order intake (constant currency), driven by EMEA and services...
Close LIVE: Report Morning July 17. Medical technology company C-Rad reports an operating profit of 28 million kronor for the second quarter (8). Organizations are pressured by faster decisions, new...
" Performance. Accountability. Execution. The beginning of a new chapter for C-RAD" First quarter January-MarchOrder intake increased 19 percent to MSEK 115 (97) (30 percent...
Track C-RAD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to C-RAD and other trending companies.